publication venue for
- Prognostic impact and gene expression analysis of peri-tumoral alveolar macrophage in resected lung adenocarcinoma. 2023
- Survival rate prediction of nasopharyngeal carcinoma patients based on MRI and gene expression using a deep neural network.. 114. 2023
- JNK pathway plays a critical role for expansion of human colorectal cancer in the context of BRG1 suppression.. 113. 2022
- First-line pembrolizumab vs chemotherapy in metastatic non-small-cell lung cancer: KEYNOTE-024 Japan subset.. 112. 2021
- First-line pembrolizumab vs chemotherapy in metastatic non-small-cell lung cancer: KEYNOTE-024 Japan subset.. 111. 2020
- Akt inhibition synergizes with polycomb repressive complex 2 inhibition in the treatment of multiple myeloma.. 110. 2019
- Exploration of resistance mechanisms for epidermal growth factor receptor-tyrosine kinase inhibitors based on plasma analysis by digital polymerase chain reaction and next-generation sequencing.. 109. 2018
- Phase I study of salazosulfapyridine in combination with cisplatin and pemetrexed for advanced non-small-cell lung cancer.. 108. 2017
- Preclinical and first-in-human phase I studies of KW-2450, an oral tyrosine kinase inhibitor with insulin-like growth factor receptor-1/insulin receptor selectivity.. 107. 2016
- Sensitivity and kinase activity of epidermal growth factor receptor (EGFR) exon 19 and others to EGFR-tyrosine kinase inhibitors.. 104. 2013
- Genetic alterations in systemic nodal and extranodal non-cutaneous lymphomas derived from mature T cells and natural killer cells.. 103. 2012
- Role of oxidation-triggered activation of JNK and p38 MAPK in black tea polyphenols induced apoptotic death of A375 cells.. 100. 2009
- Regulation of programmed death-ligand 1 expression in response to DNA damage in cancer cells: Implications for precision medicine. 2019
- Cancer/testis (CT) antigens: potential targets for immunotherapy. 2009